A new case of frontotemporal dementia and parkinsonism resulting from an intron 10 + 3-splice site mutation in the tau gene: Clinical and pathological features

Neuropathology and Applied Neurobiology

Volumn 26, Issue 4, 2000, Pages 368-378

  Tolnay, M ^a,c   Spillantini, M Grazia ^b   Rizzini, C ^b   Eccles, D ^c   Lowe, J ^d   Ellison, D ^c  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Frontotemporal dementia; FTDP 17; Mutation; Tau; Tauopathy

Indexed keywords

TAU PROTEIN;

ADULT; ARTICLE; BRAIN NERVE CELL; CASE REPORT; CELL LOSS; CHROMOSOME 17; CLINICAL FEATURE; ELECTRON MICROSCOPY; EXON; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GENE SEQUENCE; GLIOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRON; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL;

ADULT; ALTERNATIVE SPLICING; BRAIN; DEMENTIA; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRONS; MICROSCOPY, ELECTRON; MUTATION; NEUROFIBRILLARY TANGLES; PARKINSONIAN DISORDERS; PEDIGREE; TAU PROTEINS;

EID: 0033866455     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.2000.00109.x     Document Type: Article

References (49)

1. 1 Bell JE, Gentleman SM, Ironside JW et al. Prion protein immunocytochemistry - UK five centre consensus report. Neuropathol Appl Neurobiol 1997; 23: 26-35
2. 2 Bird TD, Nochlin D, Poorkaj P et al. A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L). Brain 1999; 122: 741-56
3. 3 Brun A, Englund B, Gustafson L et al. The Lund and Manchester groups. Consensus statement. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994; 57: 416-8
4. 4 Buée L, Delacourte A. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease. Brain Pathol 1999; 9:681-93
5. 5 Bugiani O, Murrell JR, Giaccone G et al. Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J Neuropathol Exp Neurol 1999; 58: 667-77
6. 6 Clark LN, Poorkaj P, Wszolek Z et al. Pathogenic implications of mutations in the tau gene in pallido -ponto - nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci USA 1998; 95: 13103-7
7. 7 Crowther RA. Straight and paired helical filaments in Alzheimer's disease have a common structural unit. Proc Natl Acad Sci USA 1991; 88: 2288-92
8. 8 Delisle MB, Murrell JR, Richardson R et al. A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy. Acta Neuropathol 1999; 98: 62-77
9. 9 D'Souza I, Poorkaj P, Hong M et al. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc Natl Acad Sci USA 1999; 96: 5598-603
10. 10 Dumanchin C, Camuzat A, Campion D et al. Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism. Hum Mol Genet 1998; 7: 1825-9
11. 11 Foster NL, Wilhelmsen K, Sima AAF et al. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conferenc. Ann Neurol 1997; 41: 706-15
12. 12 Goedert M, Spillantini MG, Crowther RA et al. Tau gene mutation in familial progressive subcortical gliosis. Nat Med 1999; 5: 454-7
13. 13 Goedert M, Jakes R, Vanmechelen E. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 1995; 189: 167-70
14. 14 Goedert M, Jakes R, Crowther RA et al. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem J 1994; 301: 872-7
15. 15 Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA. Multiple isoforms of human microtubule-associated protein tau: sequence and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 1989; 3: 519-26
16. 16 Greenberg SG, Davis P, Schein JD, Binder LI. Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J Biol Chem 1992; 267: 564-9
17. 17 Grover A, Houlden H, Baker M et al. 5′splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10. J Biol Chem 1999; 274: 15134-43
18. 18 Hardy J, Duff K, Hardy KG, Perez-Tur J, Hutton M. Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau. Nat Neurosci 1998; 1: 355-8
19. 19 Hasegawa M, Smith MJ, Iijima M, Tabira T, Goedert M. FTDP-17 mutations N279K; and S305N in tau produce increased splicing of exon 10. FEBS Lett 1999; 443: 93-6
20. 20 Hasegawa M, Jakes R, Crowther RA, Lee VM-Y, Ihara Y, Goedert M. Characterization of mAb AP422, a novel phosphorylation-dependent monoclonal antibody against tau protein. FEBS Lett 1996; 384: 25-30
21. 21 Hoffman R, Lee VM-Y, Leight S, Varga I, Otvos L. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites. Biochemistry 1997; 36: 8114-24
22. 22 Hong M, Zhukareva V, Vogelsberg-Ragaglia V et al. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 1998; 282: 1914-7
23. 23 Hulette CM, Pericak-Vance MA, Roses AD et al. Neuropathologic features of frontotemporal dementia and parkinsonism linked to chromosome 17q21-22 (FTDP-17): Duke Family 1684. J Neuropathol Exp Neurol 1999; 58: 859-66
24. 24 Hutton M, Lendon CL, Rizzu P et al. Association of missense and 5′-splice site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393: 702-5
25. 25 Iijima M, Tabira T, Poorkaj P et al. A distinct familial presenile dementia with a novel missense mutation in the tau gene. Neuroreport 1999; 10: 497-501
26. 26 Jackson M, Lowe J. The new neuropathology of degenerative frontotemporal dementias. Acta Neuropathol 1996; 91: 127-34
27. 27 Jakes R, Spillantini MG, Goedert M. Identification of two distinct synucleins from human brain. FEBS Lett 1994; 353: 27-32
28. 28 Lowe J. Degenerative non-Alzheimer dementias. Brain Pathol 1997; 7: 1047-51
29. 29 Mercken M, Vandermeeren M, Lübke U et al. Monoclonal antibodies with selective specificity for Alzheimer tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol 1992; 84: 265-72
30. 30 Mirra SS, Murell JR, Gearing M et al. Tau pathology in a family with dementia and a P301L mutation in tau. J Neuropathol Exp Neurol 1999; 58: 335-45
31. 31 Murrell J, Zolo P, Spillantini MG et al. A mutation at codon 389 (G389R) in exon 13 of the tau gene causes frontotemporal dementia with numerous Pick bodies. Clin Neuropathol 1999; 18: 145
32. 32 Nasreddine ZS, Loginov M, Clark LN et al. From genotype to phenotype: a clinical pathological, and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP-17) caused by the P301L tau mutation. Ann Neurol 1999; 45: 704-15
33. 33 Otvos L, Feiner L, Lang E, Szendrei G, Goedert M, Lee VM-Y. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res 1994; 39: 669-73
34. 34 Poorkaj P, Bird TD, Wijsman E et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998; 43: 815-25
35. 35 Reed LA, Schmidt ML, Wszolek ML et al. The neuropathology of a chromosome 17-linked autosomal dominant parkinsonism and dementia ('pallido - ponto - nigral degeneration'). J Neuropathol Exp Neurol 1998; 57: 588-601
36. 36 Rizzu P, van Swieten JC, Joosse M et al. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am J Hum Genet 1999; 64: 414-21
37. 37 Sambrook S, Fritsch EF, Maniatis T. Molecular Cloning. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989: 2.80-2.81
38. 38 Seubert P, Mawal-Dewan M, Barbour R et al. Detection of phosphorylated Ser 262 in fetal tau, adult tau and paired helical filament-tau. J Biol Chem 1995; 270: 18917-22
39. 39 Sima AAF, Defendini R, Keohane C et al. The neuropathology of chromosome 17-linked dementia. Ann Neurol 1996; 39: 734-43
40. 40 Sperfeld AD, Collatz MB, Baier H et al. FTDP-17: an early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation. Ann Neurol 1999; 46: 708-15
41. 41 Spillantini MG, Bird TD, Ghetti B. Frontotemporal dementia and parkinsonism linked to chromosome 17: a new group of tauopathies. Brain Pathol 1998; 8: 387-402
42. 42 Spillantini MG, Crowther RA, Kamphorst W, Heutink P, van Swieten JC. Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau. Am J Pathol 1998; 153: 1359-63
43. 43 Spillantini MG, Goedert M. Tau protein pathology in neurodegenerative diseases. TINS 1998; 21: 428-33
44. 44 Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 1998; 95: 7737-41
45. 45 Spillantini MG, Goedert M, Crowther RA, Murrell JR, Farlow MJ, Ghetti B. Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. Proc Natl Acad Sci USA 1997; 94: 4113-8
46. 46 Spillantini MG, Crowther RA, Goedert M. Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles. Acta Neuropathol 1996; 92: 42-8
47. 47 Tolnay M, Spillantini MG, Eccles D, Lowe J, Ellison DW. Widespread tau pathology in hereditary frontotemporal dementia and parkinsonism: family SOT 254. Neuropath Appl Neurobiol 1999; 25: 146
48. 48 Varani L, Hasegawa M, Spillantini MG et al. Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17. Proc Natl Acad Sci USA 1999; 96: 8229-34
49. 49 Zheng-Fischöfer Q, Biernat J, Mandelkow EM, Illenberger S, Godemann R, Mandelkow E. Sequential phosphorylation of tau by glycogen synthase kinase-3β and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation. Eur J Biochem 1998; 252: 542-52